SV40
SV40 or Simian Virus 40 is a polyomavirus that is found in both monkeys and humans. Like other polyomaviruses, SV40 is a DNA virus that has been found to cause tumors, but it is also used in some types of research.
History[edit]
SV40 was first discovered in 1960. It was found in monkey kidney cells, which were used to produce the polio vaccine. This led to widespread contamination of the vaccine, and it is estimated that millions of people were exposed to the virus. However, it is not clear whether this exposure has led to an increase in cancer rates.
Structure and genome[edit]
SV40 is a small, non-enveloped virus. It has a circular, double-stranded DNA genome that is approximately 5,200 base pairs in length. The genome is divided into an early region and a late region, which are separated by a regulatory region.
Replication[edit]
SV40 replicates in the nucleus of the host cell. The virus enters the cell through caveolae, small invaginations in the cell membrane. Once inside the cell, the virus travels to the nucleus, where it uncoats and releases its DNA.
Pathogenesis[edit]
SV40 is known to cause tumors in rodents, but its role in human disease is less clear. Some studies have suggested a link between SV40 and certain types of cancer, including mesothelioma, brain cancer, and bone cancer. However, other studies have not found a link, and the issue remains controversial.
Use in research[edit]
Despite its potential to cause disease, SV40 has been a valuable tool in research. It has been used to study viral replication and gene expression, and it has also been used to develop gene therapy techniques.
See also[edit]
SV40[edit]
-
Symian virus
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
